Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.

Steven H. Goldberg, MD

Research Interests

Dr. Goldberg is very interested in autoimmune disorders and their effect of the peripheral vascular system. He has extensive experience with the administration of Botulinum toxin A into the hand and wrist for vasospasm associated with Raynaud’s, scleroderma, and acute thrombosis, and performs clinical research on improving treatment and understanding of peripheral artery vasospasm, ischemic pain, and ischemic ulcerations. His team is currently enrolling patients in a prospective database to improve understanding of indications, safety, and efficacy of Botulinum toxin as an opioid alternative for ischemic pain relief and as an office procedure that can optimize digital perfusion and possibly avoid need for more invasive surgeries. These results have been presented as a Poster at the 2018 American Society for Surgery of the Hand. Research into the cost effectiveness of Botulinum toxin A for Raynaud’s is ongoing. 

Dr. Goldberg is also interested in optimizing nerve repair and has published an article on techniques to maximize nerve repair strength and methods to safely rehabilitate the injury. He has also written several articles on arthritis and management of cartilage injury. Furthermore, he has also published several textbook chapters on wrist injuries, finger and hand fractures, upper extremity arthritis, and scaphoid fractures.

He has been recognized by Rush University Medical Center with the Leonard R. Marmor Award for Adult Reconstruction 2005 for research completed on improving outcomes of elbow replacement surgery, techniques for revision arthroplasty, and description of modes of wear in failed elbow arthroplasty. During medical school, Dr. Goldberg performed a year of Research in Departments of Neurology, Microbiology, and Neuropathology at the University of Pennsylvania and published several articles on Human Herpes Virus Type 6 with respect to multiple sclerosis and CXCR3 a chemokine receptor that regulates leukocyte trafficking. This research was recognized by my receipt of the Morton McCutcheon Memorial Prize-for meritorious laboratory research in the field of experimental pathology in 1999. Dr. Goldberg was awarded 1990-1995 Summer Fellowships at the National Institutes of Health (NIH), NINDS and worked Analysis of Amino Acid Sequence of Simian and Human Foamy Viruses.